| Stage | R | % of rev | CRUS | % of rev | Gap · A − B |
|---|---|---|---|---|---|
| Revenue | $3.5B | 100.00% | $460M | 100.00% | R ×7.50 |
| Gross profit | $702M | 20.35% | $242M | 52.61% | CRUS +32.3pp |
| Operating income | $319M | 9.25% | $84M | 18.37% | CRUS +9.1pp |
| Pre-tax income | $226M | 6.55% | $94M | 20.48% | CRUS +13.9pp |
| Net income | $162M | 4.70% | $77M | 16.72% | CRUS +12.0pp |
| Stage | R | CRUS | Gap · A − B |
|---|---|---|---|
| Revenue | $3.5B100.00% | $460M100.00% | R ×7.50 |
| Gross profit | 20.35%$702M | 52.61%$242M | CRUS +32.3pp |
| Operating income | 9.25%$319M | 18.37%$84M | CRUS +9.1pp |
| Pre-tax income | 6.55%$226M | 20.48%$94M | CRUS +13.9pp |
| Net income |
| 4.70%$162M |
| 16.72%$77M |
| CRUS +12.0pp |
No shared counterparties.